Company / Operating Cash Flow per Share
CervoMed Inc. Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.69
FY2025
5-year range
-$4.97 / -$0.21
FY2021-FY2025
Trend
-105.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-4.97 to $-2.69 over the past 2 years.
Based on SEC 10-K filings.
-2.69 in FY2025.
Improved from $-4.97 to $-2.69 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 105.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.69 | -105.2% |
| FY2024 | -$1.31 | +73.6% |
| FY2023 | -$4.97 | -2282.4% |
| FY2011 | -$0.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026